Skip to content

Efficacy of Ultrasound Guided Erector Spinae Plane Block Versus Ultrasound Guided Serratus Anterior Plane Block for Postoperative Pain Control Following Video-assisted Thoracoscopic Surgeries (VATS): Randomized Control Trial

Efficacy of Ultrasound Guided Erector Spinae Plane Block Versus Ultrasound Guided Serratus Anterior Plane Block for Postoperative Pain Control Following Video-assisted Thoracoscopic Surgeries (VATS): Randomized Control Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07360028
Enrollment
50
Registered
2026-01-22
Start date
2025-12-01
Completion date
2027-12-30
Last updated
2026-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post Operative Pain Control

Keywords

post operative pain control

Brief summary

The aim of the study is to compare the analgesic efficacy of Erector spinae plane block versus Serratus anterior plane block in patients undergoing video-assisted thoracoscopic surgeries.

Detailed description

The aim of the study is to compare the analgesic efficacy of Erector spinae plane block versus Serratus anterior plane block in patients undergoing video-assisted thoracoscopic surgeries. Preoperative: - On the day before surgery, all patients will be evaluated, detailed medical and surgical history will be taken also physical and systemic examinations will be done. The following investigations will be done including complete blood count, liver enzymes, prothrombin time, partial thromboplastin time, International normalized ratio (INR) , kidney functions, serum electrolytes and ECG. All patients will be informed about the visual analogue scale (VAS) on a scale from 0 to 10 where 0 represents no pain and 10 represents the worst imaginable pain. In the pre-Anesthetic room: * baseline hemodynamics will be recorded including heart rate (HR) and mean arterial blood pressure (MAP) and An intravenous access will be inserted. * In the operating theatre, full monitors will be applied. Intraoperative: - * Fentanyl (1 μg/kg), propofol (2 mg/kg) and atracurium(0.5 mg/kg) will be given IV for general anesthesia induction. * Intubation will be done using a double-lumen endobronchial tube size 37 Fr in females and 39 Fr in males, tidal volume will be 6-8 ml/kg in case of both lungs ventilation and 4-6ml/kg during singe lung ventilation. Anesthesia will continue using isoflurane 2 vol. %, 50% O2 and 50% air. * Moreover, three milligrams of Granisetron will be given as prophylactic against nausea and vomiting post-operatively. * During operation, 6 mL/kg/h of Ringer's solution will be administered. * At the end of surgery, the patient will be positioned laterally. * All blocks will be done using ultrasound-guidance (Mindray ultrasound) using high frequency linear probe (10-12 MHZ) by the same experienced senior doctors. Group A : (25 patients) patients will receive Erector Spinae Plane Block using 20 mL of 0.25% bupivacaine. Group B: (25 patients) patients will recieve Serratus Aneterior Plane Block using 20 mL of 0.25% bupivacaine.

Interventions

Ultrasound Guided Erector Spinae Plane block using 20 mL of 0.25% bupivacaine.

Ultrasound Guided Serratus Anterior Plane Block using 20 mL of 0.25% bupivacaine.

Sponsors

Ain Shams University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Caregiver)

Eligibility

Sex/Gender
ALL
Age
25 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Patients with American Society of Anesthesiology physical status ASA I, II and III. * Patients aged between 25 and 70 years. * patients undergoing video-assisted thoracoscopic surgeries (VATS), including pleurectomy, bullectomy, sympathectomy, esophagectomy, decortication, lobectomy, and pneumonectomy.

Exclusion criteria

* Patients below age of 25 or above age of 70. * Patient refusal. * Allergy to local anesthetic drugs. * Bleeding or coagulation disorder. * Psychiatric disorders. * Infection at the needle entry site. * Renal impairment (creatinine \>1.5 ). * Hepatic impairment (Child B or C). * Patients with known Cortisol related diseases such as Cushing's Syndrome or Addison's Disease.

Design outcomes

Primary

MeasureTime frameDescription
Visual analogue scale for Assessing postoperative pain controlafter ICU admission at 2, 4, 8, 16, 24 hours post operative.Assessing The difference in postoperative pain control between both groups as determined by assessing the visual analogue scale

Countries

Egypt

Contacts

CONTACTEMAN ZAGHLOUL MADY, MSc
Emanzaghloul@med.asu.edu.eg00201013177848

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026